机构:[1]Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen Xitoutiao, Beijing 100069, China.[2]Center for Physical Examination, Xuanwu Hospital, Capital Medical University, Beijing 100050, China.首都医科大学宣武医院[3]School of Medical Sciences, Edith Cowan University, Perth, WA 6027, Australia.[4]Genos Glycobiology Research Laboratory, 10000 Zagreb, Croatia.[5]Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia
Background: Alternative N-glycosylation has significant structural and functional consequences on immunoglobulin G (IgG) and can affect immune responses, acting as a switch between pro- and anti-inflammatory IgG functionality. Studies have demonstrated that IgG N-glycosylation is associated with ageing, body mass index, type 2 diabetes and hypertension. Methods: Herein, we have demonstrated patterns of IgG glycosylation that are associated with blood lipids in a cross-sectional study including 598 Han Chinese aged 20-68 years. The IgG glycome composition was analysed by ultra-performance liquid chromatography. Results: Blood lipids were positively correlated with glycan peak GP6, whereas they were negatively correlated with GP18 (P < 0.05/57). The canonical correlation analysis indicated that initial N-glycan structures, including GP4, GP6, GP9-12, GP14, GP17, GP18 and GP23, were significantly correlated with blood lipids, including total cholesterol, total triglycerides (TG) and low-density lipoprotein (r = 0.390, P<0.001). IgG glycans patterns were able to distinguish patients with dyslipidaemia from the controls, with an area under the curve of 0.692 (95% confidence interval 0.644-0.740). Conclusions: Our findings indicated that a possible association between blood lipids and the observed loss of galactose and sialic acid, as well as the addition of bisecting GIcNAcs, which might be related to the chronic inflammation accompanying with the development and procession of dyslipidaemia.
基金:
This work was supported by Grants from National Natural Science Foundation
of China (81673247, 81370083, 81773527 and 81530087) and Australian-China
Collaborative Grant (NH&MRC-APP1112767–NSFC 81561128020).
第一作者机构:[1]Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen Xitoutiao, Beijing 100069, China.
共同第一作者:
通讯作者:
通讯机构:[1]Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen Xitoutiao, Beijing 100069, China.[3]School of Medical Sciences, Edith Cowan University, Perth, WA 6027, Australia.
推荐引用方式(GB/T 7714):
Di Liu,Xi Chu,Hao Wang,et al.The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia[J].JOURNAL OF TRANSLATIONAL MEDICINE.2018,16(1):235.doi:10.1186/s12967-018-1616-2.
APA:
Di Liu,Xi Chu,Hao Wang,Jing Dong,SiQi Ge...&Wei Wang.(2018).The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia.JOURNAL OF TRANSLATIONAL MEDICINE,16,(1)
MLA:
Di Liu,et al."The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia".JOURNAL OF TRANSLATIONAL MEDICINE 16..1(2018):235